Research Professor, Department of Orthopedic Surgery
Research Professor, Department of Biochemistry and Molecular Pharmacology
As a researcher and professor of orthopaedic surgery, biochemistry, and molecular pharmacology at NYU School of Medicine, I am an expert in osteoarthritis, the extracellular matrix, hyaluronic acid, synovial fluid, and intra-articular injection therapies.
My work has spanned three related fields—medical applications of matrix polymers, orthopaedic medicine and injection devices, and recombinant botulinum neurotoxins. Dr. Joseph Zuckerman and I founded the Center for Clinical Research, where we began developing big data approaches to personalized musculoskeletal medicine.
I am the chief executive officer of CytoDel LLC, a biopharmaceutical company that was co-developed at NYU Langone. We have engineered recombinant derivatives of botulinum neurotoxin to create therapeutic fusion proteins designed to deliver single chain antibodies into neurons.
Throughout my career, I have been deeply involved in taking inventions from the laboratory and applying them to medical practice using preclinical testing, formulation, chemistry and manufacturing controls, clinical trial design, and regulatory compliance.
Research Professor, Department of Orthopedic Surgery at NYU Grossman School of Medicine
PhD from City College
International journal of rheumatic diseases. 2022 Mar; 25(3):303-310
Science translational medicine. 2021 Jan 06; 13(575):
Clinical rheumatology. 2019 Aug; 38(8):2255-2263
Orthopedic clinics of North America. 2018 Oct; 49(4):389-396
Journal of clinical rheumatology. JCR. 2018 Sep; 24(6):295-301
Clinical rheumatology. 2018 Aug; 37(8):2251-2259
Osteoarthritis & cartilage. 2018 Feb; 26(2):245-254
Scientific reports. 2017 02 21; 7:42923